CRA

?
1) What is the term for the study on what a drug does to the body?
Pharmacodynamics study
1 of 89
The pharmaceutical industry is specialized in the discovery, development, production and marketing of:
Drugs and Medical devices for human subjects and animals
2 of 89
What is an NDA?
An application to the FDA to approve a new drug for marketing
3 of 89
Who is responsible for the safety and welfare of the subjects in clinical trial?
Everyone involved
4 of 89
What is the most important consideration when conducting clinical research?
Protection of trial subjects
5 of 89
A Clinical trial is
A study on humans to assess safety and efficacy of a new product
6 of 89
What is the term for the study that defines the amount of the drug that stays in the human body over time?
Pharmacokinetics
7 of 89
What does the letter D represent in "IND"?
Drug
8 of 89
How is the characterization of a new compound to determinate its therapeutic potential performed?
With animals, cell and tissue culture, enzymes and computer models
9 of 89
Who usually participates in Phase I clinical trials?
Less than 100 healthy voluntary subjects.
10 of 89
When did ICH GCP become effective in Europe?
1998
11 of 89
What is the regulatory authority governing medicinal products in the USA ?
FDA
12 of 89
What does the 'E' mean in the ICH guidelines, e.g. ICH E6?
Efficacy
13 of 89
What does Part E6 of ICH GCP discuss?
Good Clinical Practice
14 of 89
What is the status of Canada in ICH?
Observer
15 of 89
The Health Canada regulations on clinical trials are based on what?
ICH GCP and the FDA regulations with some additions
16 of 89
How does FDA use the ICH GCP regulations?
As legally non-binding Guidelines
17 of 89
What does MCA stand for?
Medicines Control Agency
18 of 89
What does the letter "A" in FDA mean?
Administration
19 of 89
What does the letter "A" in MedDRA mean?
Activities
20 of 89
What does the R means in CFR?
Regulations
21 of 89
What body finances the NIH studies?
DHHS
22 of 89
What does FBC stand for?
Full Blood Count
23 of 89
What is the Canadian law on clinical trials conduct?
FDA
24 of 89
What does ADME mean?
Absorption, Distribution, Metabolism and Excretion
25 of 89
What does CIOMS stand for?
Council for International Organisations of Medical Science
26 of 89
What does MRI stand for?
Magnetic Resonance Imaging
27 of 89
What are Phase II studies usually called
Dose determination study
28 of 89
What is a Phase IV study usually called
Safety surveillance study
29 of 89
What are the new Phase 0 studies usually called
Exploratory study
30 of 89
How are drugs with serious side effects (like cancer drugs) tested?
On patients with the target disease
31 of 89
For what phase do the terms for single and, multiple escalating doses SAD and MAD apply?
Phase I
32 of 89
What are Phase III studies usually called
Confirmatory study
33 of 89
Which studies are traditionally called FIH (First In Humans)?
Phase I studies
34 of 89
When are drugs usually tested on women and children?
In the late phases
35 of 89
What are Phase II studies usually called
Dose ranging study
36 of 89
What documents may FDA review?
A and C only
37 of 89
What is the definition of a CRO according to the FDA?
Legal entity, which assumes one or more obligations of sponsor
38 of 89
Who has the ultimate responsibility for the investigational drug accountability at the study site?
The Principal Investigator
39 of 89
What is FALSE about the FDA regulations?
Sponsor may develop his own rules
40 of 89
What is the name of the regulatory permission to conduct a clinical trial in USA?
IND
41 of 89
Which class are ultrasound diagnostic systems, if implants are class III ?
Class III (Moderate risk)
42 of 89
What act authorizes Health Canada to regulate therapeutic products?
The Food and Drugs Act
43 of 89
Which document allows selling a therapeutic product in Canada?
NOC (Notice Of Compliance)
44 of 89
Where are the Canadian requirements for investigational Medical Devices found?
In the Canadian Medical Devices Regulations
45 of 89
What body regulates the clinical research in Canada?
The Health Products and Food Branch (HPFB)
46 of 89
When can a sponsor start a drug clinical trial in Canada?
After receipt of No Objection Letter
47 of 89
When is the Abbreviated New Drug Submission (ANDS) used?
For generic products
48 of 89
What document must the sponsor present to Health Canada to get an authorization for a clinical trial?
Clinical Trial Application (CTA)
49 of 89
What does REC mean?
Research Ethics Committee
50 of 89
How many members should be present at IRB meetings to have quorum under ICH?
It is not specified
51 of 89
Who is responsible for the communication with the IRB/IEC?
The Principal investigator
52 of 89
What do we call the member whose primary area of interests is not in the scientific area?
Lay member
53 of 89
What are the usual timelines for a non-commercial Ethics Committee Approval ?
60 to 90 days
54 of 89
To what should IRB/IEC pay special attention?
Vulnerable subjects
55 of 89
What must the Investigator provide to IRB at the end of the study?
A summary of the trial outcome
56 of 89
How long should the IRB/IEC retain documentation according ICH GCP?
3 years after the end of the clinical trial
57 of 89
Who is responsible for the informed consent process?
The Principal investigator
58 of 89
What should be the language used in the oral and written information about the trial, including in the written informed consent form according to ICH GCP?
Non-technical
59 of 89
Who can sign a consent form on behalf of a subject according to ICH GCP?
Subject’s Legally Authorized Representative
60 of 89
According to the Declaration of Helsinki, who can obtain consent ?
The investigator or another physician, designated by him
61 of 89
If a subject is unable to read and his legally acceptable representative is also unable to read, then who should be present during the entire informed consent discussion?
An impartial witness
62 of 89
When should the informed consent be taken by a physician not engaged in the investigation, according to the Declaration of Helsinki?
When subject is in a dependent relationship to the investigator or may consent under duress
63 of 89
Who can obtain informed consent from study participants?
It should be a physician or a qualified person, to whom he delegated this responsibility
64 of 89
What is the timeline for an Investigator to report a SAE to the Sponsor?
Immediately
65 of 89
If all information for a complete report on a fatal SUSAR is not available within 7 days, what is the deadline for a follow-up report?
Another 8 days
66 of 89
What is the difference between SAE and SUSAR (Suspected Unexpected Serious Adverse Reaction)?
A SUSAR is a SAE, which is unexpected and considered related to study drug
67 of 89
What is the timeline for the Sponsor to report a life-threatening Suspected Unexpected Serious Adverse Reaction (SUSAR)?
7 days
68 of 89
A clinical trial subject breaks his leg in a skiing accident and arrives at his regular visit walking in crutches - is it an SAE?
Yes, but only if he stayed in hospital overnight, or had serious permanent complications
69 of 89
Who is responsible for the IND Safety Reports?
The Sponsor
70 of 89
What is a surrogate endpoint?
A measurement, related to the outcome and used in place of another, which is more difficult to assess
71 of 89
To show that a specific pharmacokinetic parameter was the same for a generic product as the original product, what sort of trial would you perform?
Equivalence
72 of 89
If the expected withdrawal rate after randomisation is 20% and 200 patients are required to complete the clinical trial, how many patients will you need to randomise?
250
73 of 89
What is the main purpose of blinding?
To reduce bias
74 of 89
In a trial with three treatment groups of two active treatments and a placebo, subjects are allocated so that there will be twice as many subjects taking an active treatment than on placebo. What is the minimum block size possible with the allocation
6 subjects per group
75 of 89
Who should the monitor inform immediately about ALL errors, omissions, discrepancies and protocol violations discovered during a site visit?
The Principal investigator
76 of 89
How long should Sponsor-specific trial related essential document be retained?
2 years after marketing approval or trial discontinuation
77 of 89
What information the investigator does NOT need to obtain from the IRB?
The IRB conditions for approval in case of changes in trial design
78 of 89
Who provides insurance & indemnity to trial subjects in case of trial related injury ?
The Sponsor
79 of 89
What is the FDA 1571 Form ?
IND application form
80 of 89
When would be the best time for the Sponsor to ship the investigational product to an investigator?
During the Investigator meeting to use the momentum
81 of 89
Who is responsible to assure the direct access of the CRA to the patient source documents acc. to ICH GCP?
The Investigator
82 of 89
What is NOT required from Principal investigators in the Statement of Investigator Form 1572?
Current licence from a professional order
83 of 89
Who is the person responsible to provide qualified advice on trial related medical issues not described in protocol and IB?
The Sponsor Medical Monitor
84 of 89
Who provides insurance & indemnity to trial subjects in case of trial related injury?
The Sponsor
85 of 89
The investigator may implement a deviation or a change of the protocol to eliminate an immediate hazard for the subjects without prior IRB/IEC approval or favorable opinion. What should be submitted as soon as possible to the IRB/IEC, the Sponsor and
A only
86 of 89
Who prepares the data analysis plan for the protocol?
The Study Biostatistician
87 of 89
With which of the following areas is associated to the international standard ISO-10993 as discussed in chapter 4?
Conducting clinical trials with medical devices
88 of 89
When must an investigator implement a deviation from, or change to a protocol without agreement of the sponsor and prior approval/favourable opinion of the IRB/IEC?
To eliminate an immediate hazard to trial subjects
89 of 89

Other cards in this set

Card 2

Front

The pharmaceutical industry is specialized in the discovery, development, production and marketing of:

Back

Drugs and Medical devices for human subjects and animals

Card 3

Front

What is an NDA?

Back

Preview of the front of card 3

Card 4

Front

Who is responsible for the safety and welfare of the subjects in clinical trial?

Back

Preview of the front of card 4

Card 5

Front

What is the most important consideration when conducting clinical research?

Back

Preview of the front of card 5
View more cards

Comments

No comments have yet been made

Similar Human Biology resources:

See all Human Biology resources »See all ICH resources »